-
Reunion Neuroscience Completes Take-Private Setup: Delisting & Consideration Details
Tuesday, August 1, 2023 - 3:43pm | 464Read More...Clinical-stage psychedelics biotech Reunion Neuroscience (NASDAQ: REUN) and MPM BioImpact have completed their announced plan of arrangement for MPM’s acquisition of Reunion for approximately $13.1 million. The company’s shareholders approved the transaction proposal at a...
-
Why No One Uses ARRA Bonds
Thursday, June 17, 2010 - 6:53am | 734Read More...Over the last six months, I’ve seen numerous marketing packets (mostly from law firms) advertising professional expertise to help owners/developers of real estate to get financing through ARRA bonds. Curiously, in spite of all this marketing, I have yet to hear of a private...
